Literature DB >> 8898644

Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension.

J C García-Pagàn1, C Santos, J A Barberá, A Luca, J Roca, R Rodriguez-Roisin, J Bosch, J Rodés.   

Abstract

BACKGROUND & AIMS: In healthy subjects, exercise promotes marked hemodynamic and humoral changes characterized by an increase in cardiac output, a redistribution of blood flow to muscular territories under activity, and an increase in sympathoadrenergic activity. The aim of this study was to investigate the extent to which hemodynamic and humoral changes caused by exercise may influence portal and systemic hemodynamics in patients with cirrhosis.
METHODS: In 8 patients with liver cirrhosis and portal hypertension, arterial pressure, cardiac output, portal pressure (as hepatic venous pressure gradient [HVPG]), and hepatic blood flow were measured before and at two steps of cycling exercise equivalent to 30% and 50% of their peak workload.
RESULTS: Exercise (at 30% of peak work-load) significantly increased arterial pressure and cardiac output and decreased systemic vascular resistance. This was associated with a significant increase in HVPG (from 16.7 +/- 1.5 to 19.2 +/- 1.6 mm Hg; P < 0.01) and a significant reduction in hepatic blood flow (from 1291 +/- 216 to 1034 +/- 152 mL-min-1; P < 0.05). All of these changes were intensified at 50% of target workload.
CONCLUSIONS: The present study shows that moderate exercise increases portal pressure and may therefore increase the risk of variceal bleeding in patients with esophageal varices. These findings suggest that cirrhotic patients with portal hypertension should be advised of potential risks during exercise.

Entities:  

Mesh:

Year:  1996        PMID: 8898644     DOI: 10.1053/gast.1996.v111.pm8898644

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  41 in total

Review 1.  Current management of the complications of portal hypertension: variceal bleeding and ascites.

Authors:  Nina Dib; Frédéric Oberti; Paul Calès
Journal:  CMAJ       Date:  2006-05-09       Impact factor: 8.262

Review 2.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

3.  Exercise stimulates beneficial adaptations to diminish doxorubicin-induced cellular toxicity.

Authors:  Ashley J Smuder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-08-28       Impact factor: 3.619

4.  High relative fat-free mass is important for maintaining serum albumin levels in patients with compensated liver cirrhosis.

Authors:  Kazuhiro Kotoh; Makoto Nakamuta; Marie Fukushima; Chitose Matsuzaki; Munechika Enjoji; Hironori Sakai; Hajime Nawata
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

5.  48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study.

Authors:  D Ludwig; S Schädel; A Brüning; B Schiefer; E F Stange
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

6.  Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Peter W Angus; Sanjay Saran Baijal; Yogesh Kumar Chawla; Radha Krishna Dhiman; H Janaka de Silva; Saeed Hamid; Shozo Hirota; Ming-Chih Hou; Wasim Jafri; Mobin Khan; Laurentius A Lesmana; Hock F Lui; Veena Malhotra; Hitoshi Maruyama; Debendranath Guha Mazumder; Masao Omata; Ujjal Poddar; Amrinder S Puri; Praveen Sharma; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Hasnain Ali Shah; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2008-09-05       Impact factor: 6.047

7.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

Review 8.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

9.  Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis.

Authors:  Jens-Otto Clemmesen; Annamaria Giraldi; Peter Ott; Kim Dalhoff; Bent-Adel Hansen; Fin-Stolze Larsen
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

Review 10.  Nutrition and exercise in the management of liver cirrhosis.

Authors:  Nobuyuki Toshikuni; Tomiyasu Arisawa; Mikihiro Tsutsumi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.